A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)

Androniki Bili, Scott Dobson, Jeffrey Quinones, Wanatpreeya Phongsamart, Peninnah Oberdorfer, Pope Kosalaraksa, Ron Dagan, Peter Richmond, Marissa B. Wilck, Waldimir Vallejos, Christine Nunn, Richard McFetridge, Gretchen Tamms, Rong Fu, Robert Lupinacci, Luwy Musey, Natalie Banniettis, Kara Bickham